MIT Technology Review→ original

From Big Pharma to Nature: How a Merck Chemist Became a Natural Drug Designer

Chemist Tim Chernack left his 20-year career at Merck, where he created targeted therapies for cancer and diabetes. Now he develops drugs inspired by molecules

AI-processed from MIT Technology Review; edited by Hamidun News
From Big Pharma to Nature: How a Merck Chemist Became a Natural Drug Designer
Source: MIT Technology Review. Collage: Hamidun News.
◐ Listen to article

Tim Chernack spent nearly two decades at Merck, developing targeted therapies for cancer, HIV, and diabetes that struck at disease without harming healthy cells. His work helped thousands of patients. But in 2018, already an established chemist, he took an unexpected step: he left Big Pharma and immersed himself in nature.

From the Big Pharma Lab to the Forest

After twenty years of synthetic chemistry, creating molecules from scratch for corporate assembly lines, Chernack realized the key insight: nature had already invented the most interesting molecules. Plants, fungi, microorganisms—millions of years of evolution have created chemical compounds that work flawlessly within living systems. Instead of designing the perfect molecule on a computer using theoretical models, he chose a different path: to learn from evolution. His approach is bio-inspired design (biomimicry): studying the molecular structures of living organisms, understanding the principles of how they work, and applying this knowledge to develop drugs.

Why Nature Turned Out to Be the Better Strategy

Synthetic pharmacology has created wonders over the past century. But it has encountered a fundamental challenge: even the most precisely engineered molecules sometimes cause unexpected side effects, because the body is not an isolated system but a complex network of interactions. Natural compounds work differently. They evolved within living organisms, and compatibility is built into their structure at the level of molecular biology.

  • Millions of years of natural selection filtered out toxic combinations
  • Natural molecules are often less allergenic and better tolerated
  • The planet's biodiversity is a library of millions of molecules ready for exploration
  • Modern AI enables analysis of natural components at a previously impossible scale

But natural does not always mean effective. This is where Chernack's expertise came in handy. His years in precision medicine taught him how to take a natural molecule and refine it, making it more selective and potent.

A New Specialty for a New Era

Chernack's story symbolizes a shift in pharmacology. The 20th century was the era of synthetic chemistry; the 21st looks like the era of the 'nature designer'—a specialist who combines ecology, molecular biology, AI, and pharmacology. This is neither just a biologist nor just a chemist. This is a hybrid professional who speaks the language of nature and translates it into the language of medicine. Such specialists will become critical for the next generation of drugs.

What This Means

For industry—a return to historical roots with modern tools. For young scientists—a signal about a new career path. Nature offers an open laboratory where expertise is valued just as highly, but the meaning of the work aligns with sustainability.

ZK
Hamidun News
AI news without noise. Daily editorial selection from 400+ sources. A product by Zhemal Khamidun, Head of AI at Alpina Digital.

Want to stop reading about AI and start using it?

AI News is a curated feed of AI/tech news. Hamidun Academy teaches you to use AI systematically in your work.

What do you think?
Loading comments…